Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

A number of neurodegenerative diseases of the brain are characterized by inclusions within neurons that are comprised of aggregated fibrils of hyperphosphorylated tau protein. These disorders, which ...

We treat AI like a search engine, but massive context windows offer more. Stop hugging the coast. Why 2026 is the year to cut ...

Aryan Poduri's book, "GOAT Coder," teaches children how to code through hands-on exercises and uncomplicated explanations.